BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7579718)

  • 1. Management of in situ carcinoma of the breast: lobular and ductal origin.
    White RE; Bland KI
    R I Med; 1995 Sep; 78(9):242-5. PubMed ID: 7579718
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular carcinoma in situ.
    Afonso N; Bouwman D
    Eur J Cancer Prev; 2008 Aug; 17(4):312-6. PubMed ID: 18562954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A confusing cancer.
    Health News; 1998 Aug; 4(10):1-2. PubMed ID: 9708039
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 7. [Observation of an increase in "aggressive tumor forms" in increasing incidence of breast carcinoma].
    Engelhardt C; Sauerland C; Bettges G
    Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):124-7. PubMed ID: 8674957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and treatment of breast cancer.
    Matory YL
    Curr Opin Gen Surg; 1994; ():217-23. PubMed ID: 7583973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast.
    Wood WC
    Semin Oncol; 1996 Aug; 23(4):446-52. PubMed ID: 8757271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobular neoplasia: morphology and management.
    Jorns J; Sabel MS; Pang JC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1344-9. PubMed ID: 25268198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?
    DeCensi A; Pruneri G; Guerrieri-Gonzaga A
    J Clin Oncol; 2012 Apr; 30(12):1384-6. PubMed ID: 22393083
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lobular carcinoma in situ of the breast].
    Llanos Muñoz M; Alonso Muñoz MC; Ojeda González B
    Med Clin (Barc); 1994 Oct; 103(14):553-6. PubMed ID: 7799670
    [No Abstract]   [Full Text] [Related]  

  • 14. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
    Lakhani SR; Audretsch W; Cleton-Jensen AM; Cutuli B; Ellis I; Eusebi V; Greco M; Houslton RS; Kuhl CK; Kurtz J; Palacios J; Peterse H; Rochard F; Rutgers E;
    Eur J Cancer; 2006 Sep; 42(14):2205-11. PubMed ID: 16876991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABC of breast diseases: breast cancer.
    Sainsbury JR; Anderson TJ; Morgan DA
    BMJ; 2000 Sep; 321(7263):745-50. PubMed ID: 10999911
    [No Abstract]   [Full Text] [Related]  

  • 16. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common questions about ductal carcinoma in situ.
    Dell DD
    Am J Nurs; 1997 May; 97(5):61-3, 65-6. PubMed ID: 9155799
    [No Abstract]   [Full Text] [Related]  

  • 19. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
    Fondrinier E; Guérin O; Lorimier G
    Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bilateral breast carcinoma. 12 years' experience].
    Maculotti L; Gandini F; Pradella P
    Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.